The safety and efficacy of indobufen or aspirin combined with clopidogrel in patients with acute myocardial infarction after percutaneous coronary intervention

Currently, the standard treatment for patients who have undergone percutaneous coronary intervention (PCI) following acute myocardial infarction (MI) involves dual antiplatelet therapy (DAPT) with a combination of aspirin and a potent P2Y12 receptor inhibitor. However, the potential benefits of aspi...

Descripción completa

Detalles Bibliográficos

Autores principales:	Wen-Bo Dai, Jia-Yi Ren, Su-Tao Hu, Yu-Kun Zhang, Tian-Shu Gu, Xue Wu, Jing-Kun Zhang, Jing-Jin Che, Xiang-Hong Ma, Tong Liu, Guang-Ping Li, Kang-Yin Chen
Formato:	Artigo
Lenguaje:	Inglês
Publicado:	Taylor & Francis Group 2024-12-01
Colección:	Platelets
Materias:	Acute myocardial infarction aspirin indobufen percutaneous coronary intervention
Acceso en línea:	https://www.tandfonline.com/doi/10.1080/09537104.2024.2364748
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!